Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noncardiac pulmonary edema.

G R Bernard, K L Brigham

    Comprehensive Therapy
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Acute Respiratory Distress Syndrome (ARDS) affects many patients annually, often leading to high mortality due to its varied causes. Current treatment focuses on supportive care, as specific therapies remain elusive, necessitating improved prevention and management strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
    Same author

    Long-term cognitive impairment after critical illness.

    The New England journal of medicine·2013
    Same author

    Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

    Clinical pharmacology and therapeutics·2012
    Same author

    Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.

    The pharmacogenomics journal·2012
    Same author

    Pharmacogenetic treatment of acute respiratory distress syndrome.

    Minerva anestesiologica·2011
    Same author

    Development of a large-scale de-identified DNA biobank to enable personalized medicine.

    Clinical pharmacology and therapeutics·2008
    Same journal

    Heparin-induced thrombocytopenia and thrombosis.

    Comprehensive therapy·2011
    Same journal

    Antiplatelet therapy in cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Genetics of cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Septic renal vein thrombosis complicated by septic pulmonary embolism.

    Comprehensive therapy·2011
    Same journal

    Gout and hyperuricemia.

    Comprehensive therapy·2011
    Same journal

    Problems with computerized health records.

    Comprehensive therapy·2011
    See all related articles

    Area of Science:

    • Critical Care Medicine
    • Pulmonology
    • Emergency Medicine

    Background:

    • Acute Respiratory Distress Syndrome (ARDS) is a severe clinical condition impacting over 150,000 individuals yearly in the U.S.
    • The syndrome presents with diverse etiologies, contributing to a high mortality rate of 60%–70%.
    • Despite extensive research, no specific, proven therapeutic interventions are currently available for ARDS patients.

    Purpose of the Study:

    • To review the current state of Acute Respiratory Distress Syndrome (ARDS) management.
    • To highlight the challenges in treating ARDS and the importance of supportive care.
    • To emphasize the need for enhanced prevention and daily management strategies.

    Main Methods:

    • Review of existing literature on ARDS.

    Related Experiment Videos

  • Analysis of current supportive care strategies.
  • Discussion of therapeutic challenges and future directions.

    • Main Results:

    • ARDS is characterized by high mortality, influenced by its multiple underlying causes.
    • Supportive care is the primary treatment modality, aiming to sustain patients during the healing process.
    • Advanced, invasive technologies are increasingly integral to supportive care.

    Conclusions:

    • Effective, specific therapies for ARDS are still lacking.
    • Continuous improvement in supportive measures and high-technology interventions are crucial.
    • Reducing ARDS mortality requires a concerted focus on prevention and meticulous day-to-day patient management.